ANTB
NBIX icon

AMG National Trust Bank’s Neurocrine Biosciences NBIX Stock Holding History

AMG National Trust Bank’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,797
Closed -$1.55M – 480
2026
Q1 		$1.55M Sell
11,797
-529
-4% -$70.2K 0.03% 261
2025
Q4 		$1.75M Buy
+12,326
New +$1.79M 0.04% 234

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

AMG National Trust Bank's NBIX Position: Q2 2026 in Review

AMG National Trust Bank sold out of Neurocrine Biosciences (NBIX) in Q2 2026, closing a stake of 11,797 shares — an estimated $1.55M sold.

AMG National Trust Bank first reported a position in NBIX in Q4 2025 and held it in 2 quarters. The position peaked at $1.75M in Q4 2025. 388 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • AMG National Trust Bank reported no remaining Neurocrine Biosciences position as of Q2 2026 after selling out during the quarter.
  • AMG National Trust Bank sold 11,797 Neurocrine Biosciences shares in Q2 2026, an estimated $1.55M.
  • AMG National Trust Bank first reported a position in Neurocrine Biosciences in Q4 2025 and held it in 2 quarters.
  • AMG National Trust Bank's Neurocrine Biosciences position peaked at $1.75M in Q4 2025.
  • 388 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on AMG National Trust Bank's 13F filing for Q2 2026, filed 7 Aug 2026.